Cargando…
Protocol to identify novel immunotherapy biomarkers based on transcriptomic data in human cancers
Immune checkpoint inhibitors have transformed the management of advanced cancers, but biomarkers for the prediction of therapeutic responses have not been fully uncovered. Here, we provide a step-by-step approach for the identification of novel biomarkers from public transcriptomic datasets. We comp...
Autores principales: | Mei, Jie, Cai, Yun, Xu, Rui, Zhu, Yichao, Zhao, Xinyuan, Zhang, Yan, Mao, Wenjun, Xu, Junying, Yin, Yongmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173013/ https://www.ncbi.nlm.nih.gov/pubmed/37119142 http://dx.doi.org/10.1016/j.xpro.2023.102258 |
Ejemplares similares
-
SECTM1 is upregulated in immuno-hot tumors and predicts immunotherapeutic efficacy in multiple cancers
por: Mei, Jie, et al.
Publicado: (2023) -
SECTM1 is upregulated in immuno-hot tumors and predicts immunotherapeutic efficacy in multiple cancers
por: Mei, Jie, et al.
Publicado: (2023) -
HLA class II molecule HLA-DRA identifies immuno-hot tumors and predicts the therapeutic response to anti-PD-1 immunotherapy in NSCLC
por: Mei, Jie, et al.
Publicado: (2022) -
Angiotensin-converting enzyme 2 identifies immuno-hot tumors suggesting angiotensin-(1–7) as a sensitizer for chemotherapy and immunotherapy in breast cancer
por: Mei, Jie, et al.
Publicado: (2022) -
GBP5 Identifies Immuno-Hot Tumors and Predicts the Therapeutic Response to Immunotherapy in NSCLC
por: Fan, Honghong, et al.
Publicado: (2023)